Cargando…
Implications of growth factor alterations in the treatment of pancreatic cancer
Pancreatic cancer ranks fifth as a cause of cancer-related death in the world with an overall 5-year survival rate of less than 1% and a median survival of less than a year after tumour detection. Most of these patients have already metastases at the time of diagnosis. The oncologic strategies such...
Autores principales: | Juhász, Márk, Nitsche, Barbara, Malfertheiner, Peter, Ebert, Matthias PA |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149419/ https://www.ncbi.nlm.nih.gov/pubmed/12537586 http://dx.doi.org/10.1186/1476-4598-2-5 |
Ejemplares similares
-
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009) -
Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications
por: Silverman, Brittany R., et al.
Publicado: (2016) -
Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
por: Hung, Yu-Hsuan, et al.
Publicado: (2019) -
Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine
por: Fang, Yantian, et al.
Publicado: (2013) -
Altered trafficking of mutated growth factor receptors and their associated molecules: implication for human cancers
por: Kon, Shunsuke, et al.
Publicado: (2014)